🇺🇸 FDA
Patent

US 11958862

Compounds and compositions and uses thereof

granted A61PA61P25/14A61P25/18

Quick answer

US patent 11958862 (Compounds and compositions and uses thereof) held by PGI Drug Discovery LLC expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PGI Drug Discovery LLC
Grant date
Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61P, A61P25/14, A61P25/18, A61P25/28